These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15464633)

  • 1. Economic valuation through cost-benefit analysis--possibilities and limitations.
    Hansjürgens B
    Toxicology; 2004 Dec; 205(3):241-52. PubMed ID: 15464633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the quality of data used in environmental economics research.
    Ogg C
    Qual Assur; 2000; 8(3-4):169-79. PubMed ID: 12008885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new approach to risk assessment integrating scientific evaluation and economic assessment of costs and benefits.
    Barnard RC
    Regul Toxicol Pharmacol; 1996 Oct; 24(2 Pt 1):121-5. PubMed ID: 8933625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using risk assessment, benefit-cost analysis, and real options to implement a precautionary principle.
    Farrow S
    Risk Anal; 2004 Jun; 24(3):727-35. PubMed ID: 15209941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thinking broadly about costs and benefits in ecological management.
    Costanza R
    Integr Environ Assess Manag; 2006 Apr; 2(2):166-73. PubMed ID: 16646385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.
    Weimer DL; Vining AR; Thomas RK
    Health Econ; 2009 Feb; 18(2):181-202. PubMed ID: 18566968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach in environmental valuation methods.
    Zendehdel K; De Keyser W; Van Huylenbroeck G
    Commun Agric Appl Biol Sci; 2006; 71(1):231-3. PubMed ID: 17191512
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining types of economic evaluation.
    Ngorsuraches S
    J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S21-7. PubMed ID: 19255985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-benefit, cost-effectiveness and cost-utility analyses of periodontitis prevention.
    Braegger U
    J Clin Periodontol; 2005; 32 Suppl 6():301-13. PubMed ID: 16128845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of cost-efficiency of improved life quality: methodological problems].
    Tarkhov PV; Briukhanov MV; Krugliak AP; Safiulin AA
    Gig Sanit; 2006; (5):35-7. PubMed ID: 17087210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of vector control techniques: an economic approach].
    Audibert M
    Med Trop (Mars); 2009 Apr; 69(2):185-93. PubMed ID: 19545044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thoughts concerning the economic valuation of landscapes.
    Schaeffer PV
    J Environ Manage; 2008 Nov; 89(3):146-54. PubMed ID: 17766031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive Order 12866: advantages and disadvantages of the administration's new regulatory plan on risk, benefit, and costs.
    Barnard RC
    Regul Toxicol Pharmacol; 1996 Jun; 23(3):178-82. PubMed ID: 8812959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost benefit considerations of preventing elderly falls through environmental modifications to homes in Hana, Maui.
    Ling C; Henderson S; Henderson R; Henderson M; Pedro T; Pang L
    Hawaii Med J; 2008 Mar; 67(3):65-8. PubMed ID: 18512663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking economics and risk assessment.
    Dockins C; Griffiths CW; Owens N; Simon NB; Axelrad DA
    J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):611-20. PubMed ID: 15192857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic valuation of improved process plant decision support technology.
    White DC
    ISA Trans; 2007 Jun; 46(3):437-42. PubMed ID: 17434170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis in relation to budgetary constraints and reallocative restrictions.
    Adang E; Voordijk L; Jan van der Wilt G; Ament A
    Health Policy; 2005 Oct; 74(2):146-56. PubMed ID: 16153475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.